Pfizer's Weight-Loss Data Just Upends Investor Bets
Pfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
Fund reallocation matters when priorities shift. This intro explains why adjusting allocations supports your financial plan.
21,833 articlesPfizer is stepping into a high-stakes arena long led by Lilly and Novo Nordisk. This article analyzes what pfizer's w...
June can feel like a turning point for people nearing retirement. This riskiest times year demands careful planning a...
New fiscal data show tariffs only generating revenue are not near enough to cover debt service, even as deficits wide...
A Brooklyn convenience store operator is charged with using stolen Ohio EBT card numbers to pull off nearly 3,000 fra...
As micron's earnings report almost arrives, investors weigh whether the AI memory boom can sustain MU's meteoric run....
A local resident faced a costly trap when a counterfeit permit message appeared to be the next step in the process. T...
As AI pushes data growth, memory stocks grab the spotlight. This guide explains why don’t forget about western—Wester...
In June’s shifting markets, automation stocks like UiPath are under the microscope. This article explains why ARR gro...
A sudden government shutdown of an AI model can upend markets in days. This guide breaks down what it means for inves...
Netflix stock has slipped from its mid-2025 highs, now flirting with a 52-week low. This article explains what that m...
Wendy's has surged about 40% over the past week, attracting intense options activity and renewed bets on a turnaround...
A CFO's $2.1 million sale of OUSTER shares raises questions for investors. This analysis explains what such insider m...